Condensed Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Jun. 30, 2015
Current Assets:
Cash and cash equivalents	$ 13,716,207	$ 13,452,775
Marketable securities	62,328,031	86,165,532
Accounts receivable, net of allowance for doubtful accounts of $67,475 at December 31, 2015 and $54,177 at June 30, 2015	409,225	345,627
Inventory	490,704	584,424
Other receivables	26,779	857,068
Prepaid expenses	1,490,654	1,136,103
Other current assets	315,079	945,673
Total current assets	78,776,679	103,487,202
Property and equipment, net of accumulated depreciation of $28,227,002 and $27,891,272 at December 31, 2015 and June 30, 2015, respectively	3,136,834	2,241,838
Other long-term assets	50,566	50,566
Total Assets	81,964,079	105,779,606
Current Liabilities:
Accounts payable and accrued expenses	14,946,983	11,808,223
Deferred revenues	269,515	271,667
Total current liabilities	15,216,498	12,079,890
Convertible senior notes – net of unamortized debt issuance costs of $3,010,512 at December 31, 2015 and $3,375,423 at June 30, 2015	96,989,488	96,624,577
Other liabilities	$ 1,649,518	$ 1,599,760
Commitments and Contingencies
Stockholders' Deficit:
Common stock, $.01 par value; authorized 155,000,000 shares; issued 94,741,919 shares and outstanding 94,707,194 shares at December 31, 2015; and issued 94,546,578 shares and outstanding 94,511,853 shares at June 30, 2015	$ 947,418	$ 945,465
Capital contributed in excess of par	307,165,796	305,229,354
Treasury stock, at cost, 34,725 shares at December 31, 2015 and at June 30, 2015	(458,370)	(458,370)
Accumulated deficit	(338,607,876)	(309,468,004)
Accumulated other comprehensive loss	(277,630)	(161,092)
Total Immunomedics, Inc. stockholders' deficit	(31,230,662)	(3,912,647)
Noncontrolling interest in subsidiary	(660,763)	(611,974)
Total stockholders’ deficit	(31,891,425)	(4,524,621)
Total Liabilities and Stockholders' Deficit	$ 81,964,079	$ 105,779,606